(5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid

Basic Information

View in Editor

CAS Number

87893-55-8

Molecular Formula

C20H28O3

Molecular Weight

316.44 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Flash Point

-9℃

SMILES

View in Editor

CCCCC/C=C/C=C/1\[C@@H](C/C=C\CCCC(=O)O)C=CC1=O

InChI

InChI=1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6+,18-13+/t17-/m0/s1

InChIKey

VHRUMKCAEVRUBK-GODQJPCRSA-N

LogP

5.005600000000004

Topological Polar Surface Area

54.37 Å²

Hydrogen Bond Donor/Acceptor

1 / 3

Complexity

495

Synonyms & References

English

Prosta-5,9,12,14-tetraen-1-oicacid, 11-oxo-, (5Z,12E,14E)-
15-DEOXY-DELTA12 ,DELTA14 -PROSTAGLANDIN J2
15-deoxy-Δ-12,14-Prostaglandin J2
15-deoxy-Δ12,14-Prostaglandin J2
15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard
15D-PGJ2
(5Z,12E,14E)-11-Oxo-prosta-5,9,12,14-tetraen-1-oicacid
11-OXO-PROSTA-5Z,9,12E,14Z-TETRAEN-1-OIC
15-Deoxy-D12,14-PGJ2
15-Deoxy-D-12,14-prostaglandin J2
15-DEOXY-DELTA12,14-PGJ2
15-Deoxy-delta12,14-prostaglandin
15-DEOXY-DELTA12,14-PROSTAGLANGIN J2
delta12,14-Pgj 2
PROSTAGLANDIN J2,15-DEOXY-DELTA12,14
15-Deoxy-Δ-12,14-prostaglandin J2
(5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid (ACI)
(+)-15-Deoxy-Δ12,14-prostaglandin J2
15-Deoxy-Δ12,14-PGJ2
15-Deoxy-Δ12,14-prostaglandin
15-Deoxy-Δ12,14-prostaglandin J2
15-DPGJ2
Δ12,14-15-Deoxy-PGJ2
Δ12,14-15-Deoxyprostaglandin J2
Δ12,14-PGJ 2

MDL Number

MFCD00065806

FAQ

What regulatory guidelines apply to (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid (CAS: 87893-55-8)?

The regulatory guidelines for (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid (CAS: 87893-55-8) include GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a Hazardous Substance under GHS and must comply with REACH for registration, evaluation, authorization, and restriction of chemicals. Specific use applications may require additional permits and safety data sheets (SDS).

Are there alternatives to (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid in synthesis?

There are several alternatives to (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid in synthesis. Common alternatives include other omega-9 fatty acids and their derivatives. Isomers and analogs such as (5Z,12E)- and (5Z,14E)-11-oxoprosta-5,9,12,14-tetraenoic acids are also used. Substitutes like prostaglandins and their synthetic analogs can be considered depending on the specific application.

What is the market or research trend for (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid?

The market for (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid is driven by increasing research in prostaglandin signaling pathways. Recent trends indicate growing interest in its potential therapeutic applications, particularly in inflammation and pain management. Market analysis suggests a steady demand with potential for growth in pharmaceutical and clinical research sectors.

How should waste containing (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid (CAS: 87893-55-8) be handled?

Waste containing (5Z,12E,14E)-11-Oxoprosta-5,9,12,14-tetraen-1-oic acid (CAS: 87893-55-8) should be collected in appropriate containers and stored under safe conditions. For disposal, professional waste treatment facilities should be used. Environmental precautions include preventing leaks and ensuring proper incineration or chemical treatment to minimize environmental impact. Compliance with local regulations and obtaining necessary permits is crucial.